Sorry, you need to enable JavaScript to visit this website.

INSPRA® (eplerenone) Principal Display Panel

PRINCIPAL DISPLAY PANEL - 25 mg Tablet Bottle Label

NDC 0025-1710-01

Pfizer

INSPRA®
(eplerenone) tablets

25 mg

30 Tablets
Rx only

PRINCIPAL DISPLAY PANEL - 25 mg Tablet Bottle Label

PRINCIPAL DISPLAY PANEL - 25 mg Tablet Blister Pack

INSPRA®
(eplerenone)
tablets

25 mg

G.D. Searle LLC
Division of Pfizer Inc,
NY, NY 10017

EXP & LOT AREA

Principal Display Panel - 25 mg Tablet Blister Pack

PRINCIPAL DISPLAY PANEL - 25 mg Tablet Blister Pack Box

UNIT DOSE

NDC 0025-1710-03

Pfizer

INSPRA®
(eplerenone) tablets

25 mg

For in-institution use only

100 Tablets
Rx only

Principal Display Panel - 25 mg Tablet Blister Pack Box

PRINCIPAL DISPLAY PANEL - 50 mg Tablet Bottle Label

NDC 0025-1720-03

Pfizer

INSPRA®
(eplerenone) tablets

50 mg

30 Tablets
Rx only

PRINCIPAL DISPLAY PANEL - 50 mg Tablet Bottle Label

What's New

No Current Announcements.

Contact Pfizer Medical

Report an Adverse Event
1-800-438-1985

Search

Please enter your search term(s) for INSPRA®